Global Gene Amplification Market Research and Forecast, 2018-2023
The global gene amplification market is expected to grow significantly during 2018-2023. Gene amplification is a process of producing multiple copies of a gene with the other genes remain unaffected. It can be done by duplication of a region of a DNA containing the gene. Gene duplication is the result of genetic errors in a cell or group of cells. The successful completion of the human genome project is one of the major factors to contribute to the growth of the global gene amplification market. This project was aimed at producing a reference sequence of the human genome. As a result of this project, researchers are able to find a gene that is suspected to cause an inherited disease within a few days.
The other factors contributing to the growth of the market include the increasing prevalence of chronic diseases such as cancer, infectious diseases, and so on. Apart from this, development in the molecular diagnostics, increasing drug discovery activities, and increasing healthcare expenditure across the globe is significantly growing the market of gene amplification. However, there are factors such as high cost and strict regulatory framework that hamper the growth of global gene amplification market.
Geographically market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America dominates the global gene therapy market owing to higher investment in the healthcare industry, and extensive research in genetic testing, diagnostics, and detection of chronic diseases. Asia-Pacific is anticipated to be the fastest growing market as emerging economies such as India and China are significantly contributing in the research and development, lower cost, the abundant manpower of skilled workers, and supportive government policies for research.
The companies contributing to the growth of global gene amplification market are Abbott Laboratories, Inc., QIAGEN N.V., Bayer Corporation, Becton Dickinson Company, Molecular Systems, Inc., Bio-Rad Laboratories, Inc., and so on. Majority of key players are adopting various strategies such as merger & acquisition or entering into strategic alliance with other key players from the market in order to gain a competitive edge over others and enhance their presence in the market.
RESEARCH METHODOLOGY
The market study of the global gene amplification market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE
THE REPORT COVERS
The other factors contributing to the growth of the market include the increasing prevalence of chronic diseases such as cancer, infectious diseases, and so on. Apart from this, development in the molecular diagnostics, increasing drug discovery activities, and increasing healthcare expenditure across the globe is significantly growing the market of gene amplification. However, there are factors such as high cost and strict regulatory framework that hamper the growth of global gene amplification market.
Geographically market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America dominates the global gene therapy market owing to higher investment in the healthcare industry, and extensive research in genetic testing, diagnostics, and detection of chronic diseases. Asia-Pacific is anticipated to be the fastest growing market as emerging economies such as India and China are significantly contributing in the research and development, lower cost, the abundant manpower of skilled workers, and supportive government policies for research.
The companies contributing to the growth of global gene amplification market are Abbott Laboratories, Inc., QIAGEN N.V., Bayer Corporation, Becton Dickinson Company, Molecular Systems, Inc., Bio-Rad Laboratories, Inc., and so on. Majority of key players are adopting various strategies such as merger & acquisition or entering into strategic alliance with other key players from the market in order to gain a competitive edge over others and enhance their presence in the market.
RESEARCH METHODOLOGY
The market study of the global gene amplification market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE
- Financial reports of companies involved in the market.
- Whitepapers, research-papers, and news blogs.
- An authentic database such as the National Society of Genetic Counselors, American Medical Association (AMA) and so on.
- Company websites and their product/ services catalog.
THE REPORT COVERS
- Comprehensive research methodology of global gene amplification market.
- This report also includes a detailed and extensive market overview with analyst insights & key market trends.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global gene amplification market.
- Insights about market determinants which are stimulating the global gene amplification market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World
3. MARKET DETERMINANTS
3.1. Motivators
3.1.1. Increasing Trend of Molecular Diagnostic Development
3.1.2. Increasing Drug Discovery Acitivties Across the Globe
3.1.3. Increasing Healthcare Expenditure
3.1.4. Growth in the Genomic Research
3.1.5. Increasing Prevalence of Chronic Diseases
3.2. Restraints
3.2.1. High Cost Required in Gene Amplification Process
3.2.2. Strict Regulatory Guidelines
3.3. Opportunities
3.3.1. Advancement in Technology
3.3.2. Increasing R&D Investment
4. MARKET SEGMENTATION
4.1. Global Gene Amplification Market by Technology
4.1.1. Target Amplification
4.1.2. Isothermal DNA Amplification
4.1.3. Isothermal Signal Amplification
4.1.4. Linear Gene Amplification
4.1.5. Cyclic Temperature Amplification
4.1.6. Cyclic Temperature Signal Gene Amplification
4.2. Global Gene Amplification Market by Application
4.2.1. Forensics
4.2.2. Identity
4.2.3. Food Safety
4.2.4. Paternity
4.2.5. Medical
4.2.6. Veterinary
5. COMPETITIVE LANDSCAPE
5.1. Market Share Analysis
5.2. Key Company Analysis
5.3. Key Strategy Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe (RoE)
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. COMPANY PROFILES
7.1. Abbott Laboratories, Inc.
7.2. Agilent Technologies Inc.
7.3. Arbor Biosciences
7.4. Bayer Corporation
7.5. Becton Dickinson Company
7.6. Bio-Rad Laboratories, Inc.
7.7. Biomerieux S.A.
7.8. Cepheid, Inc.
7.9. deCode Genetics, Inc.
7.10. Genomic Health, Inc.
7.11. Laboratory Corporation of America Holdings (LabCorp)
7.12. Oxford Nanopore Technologies
7.13. Pacific Biosciences of California, Inc.
7.14. Qiagen N.V.
7.15. Roche Molecular Systems, Inc.
7.16. Sequenom
7.17. Takara Bio Inc.
7.18. Thermo Fisher Scientific, Inc.
7.19. Verily Life Sciences
7.20. Veritas Genetics
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World
3. MARKET DETERMINANTS
3.1. Motivators
3.1.1. Increasing Trend of Molecular Diagnostic Development
3.1.2. Increasing Drug Discovery Acitivties Across the Globe
3.1.3. Increasing Healthcare Expenditure
3.1.4. Growth in the Genomic Research
3.1.5. Increasing Prevalence of Chronic Diseases
3.2. Restraints
3.2.1. High Cost Required in Gene Amplification Process
3.2.2. Strict Regulatory Guidelines
3.3. Opportunities
3.3.1. Advancement in Technology
3.3.2. Increasing R&D Investment
4. MARKET SEGMENTATION
4.1. Global Gene Amplification Market by Technology
4.1.1. Target Amplification
4.1.2. Isothermal DNA Amplification
4.1.3. Isothermal Signal Amplification
4.1.4. Linear Gene Amplification
4.1.5. Cyclic Temperature Amplification
4.1.6. Cyclic Temperature Signal Gene Amplification
4.2. Global Gene Amplification Market by Application
4.2.1. Forensics
4.2.2. Identity
4.2.3. Food Safety
4.2.4. Paternity
4.2.5. Medical
4.2.6. Veterinary
5. COMPETITIVE LANDSCAPE
5.1. Market Share Analysis
5.2. Key Company Analysis
5.3. Key Strategy Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe (RoE)
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. COMPANY PROFILES
7.1. Abbott Laboratories, Inc.
7.2. Agilent Technologies Inc.
7.3. Arbor Biosciences
7.4. Bayer Corporation
7.5. Becton Dickinson Company
7.6. Bio-Rad Laboratories, Inc.
7.7. Biomerieux S.A.
7.8. Cepheid, Inc.
7.9. deCode Genetics, Inc.
7.10. Genomic Health, Inc.
7.11. Laboratory Corporation of America Holdings (LabCorp)
7.12. Oxford Nanopore Technologies
7.13. Pacific Biosciences of California, Inc.
7.14. Qiagen N.V.
7.15. Roche Molecular Systems, Inc.
7.16. Sequenom
7.17. Takara Bio Inc.
7.18. Thermo Fisher Scientific, Inc.
7.19. Verily Life Sciences
7.20. Veritas Genetics
LIST OF TABLES
TABLE # 1 GLOBAL GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL TARGET AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL ISOTHERMAL DNA AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL ISOTHERMAL SIGNAL AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL LINEAR GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL CYCLING TEMPERATURE DNA AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL CYCLING TEMPERATURE SIGNAL GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL FORENSICS GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL IDENTITY GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL FOOD SAFETY GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL PATERNITY GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL MEDICAL GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL VETERINARY GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 15 GLOBAL GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 16 NORTH AMERICAN GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 17 NORTH AMERICAN GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 18 NORTH AMERICAN GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 19 EUROPEAN GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 20 EUROPEAN GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 21 EUROPEAN GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 22 ASIA-PACIFIC GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 23 ASIA-PACIFIC GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 24 ASIA-PACIFIC GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 25 REST OF THE WORLD GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 26 REST OF THE WORLD GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 1 GLOBAL GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL TARGET AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL ISOTHERMAL DNA AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL ISOTHERMAL SIGNAL AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL LINEAR GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL CYCLING TEMPERATURE DNA AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL CYCLING TEMPERATURE SIGNAL GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL FORENSICS GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL IDENTITY GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL FOOD SAFETY GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL PATERNITY GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL MEDICAL GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL VETERINARY GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 15 GLOBAL GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 16 NORTH AMERICAN GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 17 NORTH AMERICAN GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 18 NORTH AMERICAN GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 19 EUROPEAN GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 20 EUROPEAN GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 21 EUROPEAN GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 22 ASIA-PACIFIC GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 23 ASIA-PACIFIC GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 24 ASIA-PACIFIC GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
TABLE # 25 REST OF THE WORLD GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2017-2023 ($ MILLION)
TABLE # 26 REST OF THE WORLD GENE AMPLIFICATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2017-2023 ($ MILLION)
LIST OF FIGURES
FIGURE # 1 GLOBAL GENE AMPLIFICATION MARKET SHARE BY TECHNOLOGY, 2017 VS 2023 (IN %)
FIGURE # 2 GLOBAL GENE AMPLIFICATION MARKET SHARE BY APPLICATION, 2017 VS 2023 (IN %)
FIGURE # 3 GLOBAL GENE AMPLIFICATION MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (IN %)
FIGURE # 4 US GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 5 CANADA GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 UK GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 FRANCE GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 GERMANY GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 ITALY GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 SPAIN GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 ROE GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 INDIA GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 CHINA GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 JAPAN GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 REST OF ASIA-PACIFIC GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 REST OF THE WORLD GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 1 GLOBAL GENE AMPLIFICATION MARKET SHARE BY TECHNOLOGY, 2017 VS 2023 (IN %)
FIGURE # 2 GLOBAL GENE AMPLIFICATION MARKET SHARE BY APPLICATION, 2017 VS 2023 (IN %)
FIGURE # 3 GLOBAL GENE AMPLIFICATION MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (IN %)
FIGURE # 4 US GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 5 CANADA GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 UK GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 FRANCE GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 GERMANY GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 ITALY GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 SPAIN GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 ROE GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 INDIA GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 CHINA GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 JAPAN GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 REST OF ASIA-PACIFIC GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 REST OF THE WORLD GENE AMPLIFICATION MARKET SIZE, 2017-2023 ($ MILLION)
